Koers Aeolus Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2015 | 3,11 mln. 2,86 mln. | Omzet 2016 | 2,08 mln. 1,91 mln. | Marktkapitalisatie | 28,9 mln. 26,58 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | -2 mln. -1,84 mln. | Nettowinst (verlies) 2016 | -3 mln. -2,76 mln. | EV/omzet 2015 | 10,8 x |
Nettoschuld 2015 | 908K 835K | Nettoliquiditeiten 2016 | 3,16 mln. 2,9 mln. | EV/omzet 2016 | 12,4 x |
K/w-verhouding 2015 |
-12
x | K/w-verhouding 2016 |
-4,67
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 01-06-05 |
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 08-05-13 |
John Clerici
BRD | Director/Board Member | 54 | 08-05-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,87% | 49,46 mld. | |
+1,35% | 42,58 mld. | |
+49,11% | 42,49 mld. | |
-4,22% | 29,09 mld. | |
+11,66% | 26,61 mld. | |
-22,81% | 18,64 mld. | |
+7,89% | 13,16 mld. | |
+29,92% | 12,55 mld. | |
+24,17% | 12,1 mld. |
- Beurs
- Aandelen
- Koers AOLS
- Koers